Quantbot Technologies LP Increases Stock Position in Astera Labs, Inc. $ALAB

Key Points

• Quantbot Technologies LP significantly increased its stake in Astera Labs by 372.8%, now owning 146,551 shares valued at approximately $8.7 million.
• Astera Labs recently reported $0.44 earnings per share for the quarter, exceeding analyst expectations, with revenue growing by 149.5% year-over-year.
• Analysts have varying ratings for Astera Labs, with a consensus of "Moderate Buy" and an average price target of $129.13, reflecting optimism about the company's potential.

Quantbot Technologies LP grew its stake in shares of Astera Labs, Inc. (NASDAQ:ALAB - Free Report) by 372.8% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 146,551 shares of the company's stock after buying an additional 115,553 shares during the period. Quantbot Technologies LP owned 0.09% of Astera Labs worth $8,745,000 as of its most recent SEC filing.

Several other institutional investors also recently made changes to their positions in ALAB. GAMMA Investing LLC grew its stake in shares of Astera Labs by 55.7% during the 1st quarter. GAMMA Investing LLC now owns 794 shares of the company's stock valued at $47,000 after buying an additional 284 shares during the period. Sound Income Strategies LLC raised its position in shares of Astera Labs by 34.7% during the 1st quarter. Sound Income Strategies LLC now owns 792 shares of the company's stock valued at $47,000 after acquiring an additional 204 shares in the last quarter. Harbour Investments Inc. lifted its stake in Astera Labs by 351.7% during the first quarter. Harbour Investments Inc. now owns 795 shares of the company's stock worth $47,000 after purchasing an additional 619 shares during the last quarter. Migdal Insurance & Financial Holdings Ltd. bought a new position in Astera Labs during the first quarter worth $48,000. Finally, Hazlett Burt & Watson Inc. lifted its stake in Astera Labs by 1,670.0% during the first quarter. Hazlett Burt & Watson Inc. now owns 885 shares of the company's stock worth $53,000 after purchasing an additional 835 shares during the last quarter. 60.47% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several research firms recently weighed in on ALAB. Zacks Research upgraded shares of Astera Labs to a "strong-buy" rating in a research note on Tuesday, August 12th. William Blair began coverage on shares of Astera Labs in a research note on Thursday, May 22nd. They set an "outperform" rating on the stock. Northland Capmk lowered shares of Astera Labs from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, July 22nd. Wall Street Zen upgraded shares of Astera Labs from a "hold" rating to a "buy" rating in a research note on Saturday. Finally, Stifel Nicolaus set a $145.00 price objective on shares of Astera Labs and gave the stock a "buy" rating in a research note on Monday, August 4th. Three analysts have rated the stock with a hold rating, fifteen have issued a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat.com, Astera Labs presently has a consensus rating of "Moderate Buy" and a consensus price target of $129.13.

Astera Labs Trading Down 2.5%

ALAB stock opened at $185.85 on Monday. Astera Labs, Inc. has a 1 year low of $36.85 and a 1 year high of $199.47. The company has a fifty day simple moving average of $115.49 and a 200 day simple moving average of $90.13. The firm has a market cap of $30.89 billion, a PE ratio of 331.88, a PEG ratio of 4.71 and a beta of 1.39.

Astera Labs (NASDAQ:ALAB - Get Free Report) last released its quarterly earnings data on Tuesday, August 5th. The company reported $0.44 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.33 by $0.11. Astera Labs had a net margin of 16.54% and a return on equity of 9.53%. The business had revenue of $191.93 million during the quarter, compared to analyst estimates of $172.46 million. During the same quarter in the previous year, the business earned $0.13 EPS. Astera Labs's quarterly revenue was up 149.5% compared to the same quarter last year. As a group, analysts forecast that Astera Labs, Inc. will post 0.34 EPS for the current fiscal year.

Insiders Place Their Bets

In related news, CFO Michael Truett Tate sold 100,000 shares of Astera Labs stock in a transaction on Tuesday, August 12th. The shares were sold at an average price of $191.19, for a total value of $19,119,000.00. Following the completion of the sale, the chief financial officer owned 401,496 shares of the company's stock, valued at approximately $76,762,020.24. The trade was a 19.94% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, COO Sanjay Gajendra sold 280,000 shares of Astera Labs stock in a transaction on Thursday, August 7th. The shares were sold at an average price of $170.02, for a total transaction of $47,605,600.00. Following the completion of the sale, the chief operating officer directly owned 5,525,545 shares of the company's stock, valued at approximately $939,453,160.90. The trade was a 4.82% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 2,176,436 shares of company stock worth $259,714,061 in the last 90 days. 12.50% of the stock is owned by corporate insiders.

Astera Labs Company Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.